IDO1 and cancer: So the accumulation of immunosuppressive cells and increased levels of immunosuppressive molecules such as PD-1 ligand (PD-L1) and indoleamine 2,3-dioxygenase 1 (IDO1) are directly associated with poor prognosis and unfavorable disease outcomes in patients with cancer (4–6).